273 related articles for article (PubMed ID: 16081467)
1. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.
Berry FB; Tamimi Y; Carle MV; Lehmann OJ; Walter MA
Hum Mol Genet; 2005 Sep; 14(18):2619-27. PubMed ID: 16081467
[TBL] [Abstract][Full Text] [Related]
2. A novel missense mutation and two microrearrangements in the FOXC2 gene of three families with lymphedema-distichiasis syndrome.
Fauret AL; Tuleja E; Jeunemaitre X; Vignes S
Lymphology; 2010 Mar; 43(1):14-8. PubMed ID: 20552815
[TBL] [Abstract][Full Text] [Related]
3. Novel FOXC2 missense mutation identified in patient with lymphedema-distichiasis syndrome and review.
Dellinger MT; Thome K; Bernas MJ; Erickson RP; Witte MH
Lymphology; 2008 Sep; 41(3):98-102. PubMed ID: 19013876
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1.
Saleem RA; Banerjee-Basu S; Berry FB; Baxevanis AD; Walter MA
Hum Mol Genet; 2003 Nov; 12(22):2993-3005. PubMed ID: 14506133
[TBL] [Abstract][Full Text] [Related]
5. Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene.
Vreeburg M; Heitink MV; Damstra RJ; Moog U; van Geel M; van Steensel MA
Int J Dermatol; 2008 Nov; 47 Suppl 1():52-5. PubMed ID: 18986489
[TBL] [Abstract][Full Text] [Related]
6. The wing 2 region of the FOXC1 forkhead domain is necessary for normal DNA-binding and transactivation functions.
Murphy TC; Saleem RA; Footz T; Ritch R; McGillivray B; Walter MA
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2531-8. PubMed ID: 15277473
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
[TBL] [Abstract][Full Text] [Related]
8. Lymphedema-distichiasis syndrome without FOXC2 mutation: evidence for chromosome 16 duplication upstream of FOXC2.
Witte MH; Erickson RP; Khalil M; Dellinger M; Bernas M; Grogan T; Nitta H; Feng J; Duggan D; Witte CL
Lymphology; 2009 Dec; 42(4):152-60. PubMed ID: 20218083
[TBL] [Abstract][Full Text] [Related]
9. FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function.
Tavian D; Missaglia S; Maltese PE; Michelini S; Fiorentino A; Ricci M; Serrani R; Walter MA; Bertelli M
Oncotarget; 2016 Aug; 7(34):54228-54239. PubMed ID: 27276711
[TBL] [Abstract][Full Text] [Related]
10. Essential structural and functional determinants within the forkhead domain of FOXC1.
Saleem RA; Banerjee-Basu S; Murphy TC; Baxevanis A; Walter MA
Nucleic Acids Res; 2004; 32(14):4182-93. PubMed ID: 15299087
[TBL] [Abstract][Full Text] [Related]
11.
Tavian D; Missaglia S; Michelini S; Maltese PE; Manara E; Mordente A; Bertelli M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698337
[No Abstract] [Full Text] [Related]
12. A Chinese pedigree of lymphoedema-distichiasis syndrome with a novel mutation in the FOXC2 gene.
Zhu LL; Lv YN; Chen HD; Gao XH
Clin Exp Dermatol; 2014 Aug; 39(6):731-3. PubMed ID: 24984567
[TBL] [Abstract][Full Text] [Related]
13. Novel mutation in the FOXC2 gene in three generations of a family with lymphoedema-distichiasis syndrome.
Sutkowska E; Gil J; Stembalska A; Hill-Bator A; Szuba A
Gene; 2012 Apr; 498(1):96-9. PubMed ID: 22349027
[TBL] [Abstract][Full Text] [Related]
14. Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA-Binding Activity and Transcriptional Activation.
Zhang L; He J; Han B; Lu L; Fan J; Zhang H; Ge S; Zhou Y; Jia R; Fan X
Int J Biol Sci; 2016; 12(9):1114-20. PubMed ID: 27570485
[TBL] [Abstract][Full Text] [Related]
15. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2.
Rezaie T; Ghoroghchian R; Bell R; Brice G; Hasan A; Burnand K; Vernon S; Mansour S; Mortimer P; Jeffery S; Child A; Sarfarazi M
Eur J Hum Genet; 2008 Mar; 16(3):300-4. PubMed ID: 18197197
[TBL] [Abstract][Full Text] [Related]
16. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
Fang J; Dagenais SL; Erickson RP; Arlt MF; Glynn MW; Gorski JL; Seaver LH; Glover TW
Am J Hum Genet; 2000 Dec; 67(6):1382-8. PubMed ID: 11078474
[TBL] [Abstract][Full Text] [Related]
17. Novel missense mutations in the FOXC2 gene alter transcriptional activity.
van Steensel MA; Damstra RJ; Heitink MV; Bladergroen RS; Veraart J; Steijlen PM; van Geel M
Hum Mutat; 2009 Dec; 30(12):E1002-9. PubMed ID: 19760751
[TBL] [Abstract][Full Text] [Related]
18. A case of lymphedema-distichiasis syndrome carrying a new de novo frameshift FOXC2 mutation.
Fabretto A; Shardlow A; Faletra F; Lepore L; Hladnik U; Gasparini P
Ophthalmic Genet; 2010 Jun; 31(2):98-100. PubMed ID: 20450314
[TBL] [Abstract][Full Text] [Related]
19. Age of onset in hereditary lymphedema.
Levinson KL; Feingold E; Ferrell RE; Glover TW; Traboulsi EI; Finegold DN
J Pediatr; 2003 Jun; 142(6):704-8. PubMed ID: 12838201
[TBL] [Abstract][Full Text] [Related]
20. Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice.
Noon A; Hunter RJ; Witte MH; Kriederman B; Bernas M; Rennels M; Percy D; Enerbäck S; Erickson RP
Lymphology; 2006 Jun; 39(2):84-94. PubMed ID: 16910099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
